• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 and Blood Safety: Help with a Dilemma.

作者信息

Dodd Roger Y, Stramer Susan L

机构信息

Medical Office, American Red Cross.

Scientific Affairs, American Red Cross.

出版信息

Transfus Med Rev. 2020 Apr;34(2):73-74. doi: 10.1016/j.tmrv.2020.02.004. Epub 2020 Feb 26.

DOI:10.1016/j.tmrv.2020.02.004
PMID:32147378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7127327/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52c2/7127327/358f4fa380a7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52c2/7127327/8a729b5c5c23/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52c2/7127327/358f4fa380a7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52c2/7127327/8a729b5c5c23/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52c2/7127327/358f4fa380a7/gr2_lrg.jpg

相似文献

1
COVID-19 and Blood Safety: Help with a Dilemma.2019冠状病毒病与血液安全：应对两难困境
Transfus Med Rev. 2020 Apr;34(2):73-74. doi: 10.1016/j.tmrv.2020.02.004. Epub 2020 Feb 26.
2
Balancing Supply and Demand for Blood during the COVID-19 Pandemic.在新冠疫情期间平衡血液供需
Anesthesiology. 2020 Jul;133(1):16-18. doi: 10.1097/ALN.0000000000003341.
3
[Glucocorticoid for coronavirus disease 2019: a dilemma].[2019冠状病毒病的糖皮质激素治疗：一个两难困境]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):278. doi: 10.3760/cma.j.cn121430-20200309-00352.
4
Treatments for COVID-19: emerging drugs against the coronavirus.新冠病毒病的治疗方法：对抗冠状病毒的新型药物
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.9982.
5
The Impact of COVID-19 on Italy: A Lesson for the Future.新冠疫情对意大利的影响：未来之鉴。
Int J Occup Environ Med. 2020 Jul 10;11(3):151-152. doi: 10.34172/ijoem.2020.1984. Epub 2020 Mar 30.
6
Treatments for COVID-19: emerging drugs against the coronavirus - reply.新型冠状病毒肺炎的治疗方法：对抗冠状病毒的新型药物——回复
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
7
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].基于严重急性呼吸综合征（SARS）尸检的新型冠状病毒肺炎（COVID-19）分析
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
8
[Determination Methods of 2019 Novel Coronavirus (SARS-CoV-2)].[2019新型冠状病毒（严重急性呼吸综合征冠状病毒2）的检测方法]
Zhongguo Yi Liao Qi Xie Za Zhi. 2020 Apr 8;44(4):359-362. doi: 10.3969/j.issn.1671-7104.2020.04.017.
9
[DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].[德国关于结核病、卡介苗和新型冠状病毒肺炎（严重急性呼吸综合征冠状病毒2型引起的2019冠状病毒病的官方缩写）的建议]
Pneumologie. 2020 Jul;74(7):412-416. doi: 10.1055/a-1199-6721. Epub 2020 Jul 16.
10
[COVID-19-never waste a crisis?!].[新冠疫情——切莫浪费一场危机？！]
Radiologe. 2020 Oct;60(10):891-892. doi: 10.1007/s00117-020-00750-x.

引用本文的文献

1
Plasma procurement and plasma product safety in light of the COVID-19 pandemic from the perspective of the plasma industry.考虑到 COVID-19 大流行，从血浆行业的角度来看血浆采购和血浆产品安全性。
Vox Sang. 2022 Jun;117(6):780-788. doi: 10.1111/vox.13267. Epub 2022 Mar 17.
2
Recent Advancements on COVID-19: A Comprehensive Review.新型冠状病毒肺炎的最新进展：全面综述
Int J Gen Med. 2021 Dec 24;14:10351-10372. doi: 10.2147/IJGM.S339475. eCollection 2021.
3
The transmission modes and sources of COVID-19: A systematic review.新型冠状病毒肺炎的传播模式与来源：一项系统综述
Int J Surg Open. 2020;26:125-136. doi: 10.1016/j.ijso.2020.08.017. Epub 2020 Sep 11.
4
Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion.从尼日利亚队列的血浆样本中检测到低水平的 SARS-CoV-2 RNA：对输血的影响。
PLoS One. 2021 Jun 10;16(6):e0252611. doi: 10.1371/journal.pone.0252611. eCollection 2021.
5
Coronavirus disease-2019 pandemic: Maintaining an adequate and safe supply of blood and blood products.2019年冠状病毒病大流行：维持充足且安全的血液及血液制品供应。
Asian J Transfus Sci. 2020 Jul-Dec;14(2):117-118. doi: 10.4103/ajts.AJTS_49_20. Epub 2020 Dec 19.
6
Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama.巴拿马献血者和医护人员中用于检测抗SARS-CoV-2 IgM和IgG抗体的即时检测的性能及血清流行率
Front Med (Lausanne). 2021 Mar 2;8:616106. doi: 10.3389/fmed.2021.616106. eCollection 2021.
7
Impact of mobility restriction in COVID-19 superspreading events using agent-based model.使用基于主体模型研究行动限制对新冠病毒超级传播事件的影响。
PLoS One. 2021 Mar 18;16(3):e0248708. doi: 10.1371/journal.pone.0248708. eCollection 2021.
8
COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications.COVID-19 大流行与输血医学：全球性挑战及其影响。
Ann Hematol. 2021 May;100(5):1115-1122. doi: 10.1007/s00277-021-04441-y. Epub 2021 Feb 1.
9
How should we use convalescent plasma therapies for the management of COVID-19?我们应该如何使用恢复期血浆疗法来治疗 COVID-19？
Blood. 2021 Mar 25;137(12):1573-1581. doi: 10.1182/blood.2020008903.
10
Detection of novel coronavirus (SARS-CoV-2) RNA in peripheral blood specimens.检测外周血标本中的新型冠状病毒（SARS-CoV-2）RNA。
J Transl Med. 2020 Nov 2;18(1):412. doi: 10.1186/s12967-020-02589-1.